One of the key aspects to the global wound management market that is often overlooked is the actual diversity of products and technologies in use and in development. Despite the fact that wound management is arguably the oldest area of medicine, an incredibly wide range of approaches have been developed to optimize conditions for wound healing or otherwise facilitate the healing of wounds that range from acute, surgically created to chronic, disease-linked wounds.
With a wide range of active competitors exhibiting a correspondingly wide range of strengths in different wound care product areas, the distribution of the market varies widely by product type.
Below is illustrated the market shares of companies in wound management by product segment. As is clear from an overview, there are a few segments in which select competitors dominate, but the general rule is that each segment is dominated or distributed across a varying list of competitors.
D: Smith & Nephew
F: B. Braun
N: UDL Laboratories
P: Integra LifeSciences
Q: Sanofi Biosurgery
S: Shire Regenerative Medicine
Source: MedMarket Diligence, LLC; Report #S249: “Wound Management, Worldwide Market and Forecast to 2020: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World.”
See also “Worldwide Surgical Sealants, Glues, Hemostats, Other Wound Closure and Anti-Adhesion,” Report #S190.